Total Payments
$5,303
2024 Payments
$576.52
Companies
41
Transactions
331
Medicare Patients
3,082
Medicare Billing
$260,427
Payment Breakdown by Category
Food & Beverage$5,303 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,303 | 331 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $799.17 | 50 | $0 (2024) |
| Novo Nordisk Inc | $695.84 | 47 | $0 (2024) |
| Lilly USA, LLC | $551.66 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $389.18 | 20 | $0 (2024) |
| Amarin Pharma Inc. | $275.35 | 13 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $229.73 | 16 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $222.97 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $222.76 | 14 | $0 (2024) |
| Allergan, Inc. | $219.57 | 14 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $200.46 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $576.52 | 31 | Novo Nordisk Inc ($159.66) |
| 2023 | $374.27 | 22 | Novo Nordisk Inc ($148.97) |
| 2022 | $158.29 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($82.15) |
| 2021 | $774.73 | 49 | Amarin Pharma Inc. ($83.17) |
| 2020 | $914.22 | 54 | Amarin Pharma Inc. ($137.36) |
| 2019 | $812.14 | 53 | Novo Nordisk Inc ($149.44) |
| 2018 | $726.76 | 49 | AstraZeneca Pharmaceuticals LP ($178.03) |
| 2017 | $965.82 | 65 | AstraZeneca Pharmaceuticals LP ($208.79) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 2 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 01/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 11/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.88 | General |
| 09/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Respiratory | ||||||
| 08/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.40 | General |
| 08/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Diabetes | ||||||
| 07/27/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Obesity | ||||||
| 07/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 05/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: DIABETES | ||||||
| 04/20/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 03/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 03/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 774 | 1,194 | $225,994 | $67,637 |
| 2022 | 10 | 666 | 957 | $202,526 | $59,195 |
| 2021 | 14 | 793 | 1,173 | $184,353 | $70,121 |
| 2020 | 16 | 849 | 1,353 | $185,711 | $63,475 |
Total Patients
3,082
Total Services
4,677
Medicare Billing
$260,427
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 24 | 25 | $1,250 | $299.15 | 23.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 25 | $1,125 | $231.92 | 20.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 24 | 196 | $2,940 | $199.18 | 6.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 15 | 16 | $80.00 | $51.85 | 64.8% |
About Dr. Jeffrey Mcdaniel, M.D
Dr. Jeffrey Mcdaniel, M.D is a Sports Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366576282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Mcdaniel, M.D has received a total of $5,303 in payments from pharmaceutical and medical device companies, with $576.52 received in 2024. These payments were reported across 331 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,303).
As a Medicare-enrolled provider, Mcdaniel has provided services to 3,082 Medicare beneficiaries, totaling 4,677 services with total Medicare billing of $260,427. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Midlothian, TX
- Active Since 03/15/2007
- Last Updated 04/20/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1366576282
Products in Payments
- FARXIGA (Drug) $634.76
- JARDIANCE (Drug) $431.67
- Vascepa (Drug) $275.35
- Ozempic (Drug) $273.70
- TRULICITY (Drug) $214.06
- UBRELVY (Drug) $157.97
- MOUNJARO (Drug) $140.06
- XARELTO (Drug) $138.84
- TRELEGY ELLIPTA (Drug) $128.64
- Victoza (Drug) $119.13
- Trintellix (Drug) $107.14
- BREZTRI (Drug) $101.93
- SOLIQUA 100/33 (Biological) $89.69
- Rybelsus (Drug) $87.03
- TRINTELLIX (Drug) $86.29
- Livalo (Drug) $82.53
- VYVANSE (Drug) $76.95
- Wegovy (Drug) $73.96
- JANUVIA (Drug) $69.38
- CONTRAVE (Drug) $68.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.